Sep 23, 2025
Bridge to Life Announces the Appointment of Life Sciences Industry Veteran Brian Lenz as Chief Financial Officer
Sep 18, 2025
First-Ever Multicenter Study of Hypothermic Oxygenated Perfusion (HOPE) with VitaSmart™ in Pediatric Liver Transplants Confirms Safety and Favorable Outcomes
Aug 06, 2025
New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, Economic and Immunomodulatory Advantages in Liver Transplantation
Aug 04, 2025
First-Ever Comparative Study of Hypothermic Oxygenated Machine Perfusion (HOPE) with Normothermic Machine Perfusion (NMP) in Liver Transplantation Shows Better Outcomes With HOPE
Jun 24, 2025
Bridge to Life Announces New FDA-Approved Indication for EasiSlush® Sodium Chloride Solution for Slush Preparation
May 15, 2025
Bridge to Life Announces Abstract Presentations at The 2025 International Congress of the International Liver Transplantation Society (ILTS) in Singapore, May 28-31, 2025
Dec 18, 2024
Bridge to Life Acquires VitaSmart(TM) Hypothermic Oxygenated Machine Perfusion System from Medica S.p.A.
Nov 14, 2024
Bridge to Life Ltd. Achieves Global Milestone Using Hypothermic Oxygenated Perfusion (HOPE) and VitaSmart(TM) System
Oct 25, 2024
Bridge to Life and ULS Coimbra Announce Collaboration to Enhance Preservation of Livers Awaiting Transplantation
Oct 21, 2024
Portuguese Transplant Center Analysis of First 100 Cases of Hypothermic Oxygenated PErfusion (HOPE) in Liver Transplantation Demonstrates Increased Use of Marginal Grafts, Making More Livers Available for Transplantation
Jun 04, 2024
Latest Results from End-Ischemic HOPE U.S. Randomized Clinical Trial for Liver Transplantation Show Safety, Reduced Early Allograft Dysfunction, and Shorter Hospital Stays with HOPE
Apr 02, 2024
Bridge to Life Announces Abstract Presentations at The European Society for Transplantation's ELITA Summit 2024 in Madrid, Spain, April 18-20, 2024
Feb 05, 2024
Bridge to Life Reintroduces EasiSlush® to the US Market, Meeting High Demand for Easy-to-Use Sterile Slush for Organ Transplantation